Global Cancer Biomarkers Market to Reach US$ 77.0 Billion by 2032, Impelled by Rising Incidences of Cancer

July 20, 2022 | Healthcare

IMARC Group’s latest report, titled “Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2024-2032,” finds that the global cancer biomarkers market size reached US$ 27.9 Billion in 2023. Cancer biomarkers refer to biological molecules produced by the cancer cells or other cells in the body in response to cancer. Enzymes, peptides, proteins, nucleic acids, genes, and specific cells are some of the most commonly used biomarkers. They indicate the presence of cancer in the blood, tissues, or other fluids of the body. They are widely used for disease diagnosis, screening, establishing prognosis, monitoring treatment, and detecting the chances of relapse. They also assist healthcare professionals in tracking the progression of the disease, identifying invasive and non-invasive tumors, and recording treatment efficacy. As a result, cancer biomarkers find extensive applications as prognostics, surrogate endpoints, diagnostics, and personalized medicines across the healthcare industry.

Global Cancer Biomarkers Market Trends:

The rising incidences of cancer, such as breast, prostate, cervical, lung, and colorectal cancer, represent the primary factor driving the market growth. Besides this, the increasing usage of cancer biomarkers in early cancer detection, managing treatment, and predicting accurate outcomes is another major growth-inducing factor. Additionally, due to the lack of standard diagnosis, there has been a significant shift toward personalized medicine for cancer treatment. In line with this, the growing awareness regarding the importance of early cancer diagnosis among healthcare professionals and patients has augmented the demand for cancer biomarkers. Furthermore, several key players are extensively investing in research and development (R&D) activities to introduce innovative diagnostic products. Along with this, recent technological advancements in genetic biomarker discovery, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), gene expression profiling (microarray), and proteomics, have propelled market growth. Other factors, including the rising regulatory approvals of novel drugs and diagnostics, improving healthcare infrastructure, surging government funding for drug development, increasing consumer healthcare spending, and availability of favorable reimbursement policies, are also providing a positive thrust to the market growth. Looking forward, IMARC Group expects the market value to reach US$ 77.0 Billion by 2032, expanding at a CAGR of 11.7% during 2024-2032.

Market Summary:

  • Based on profiling technology, the market has been segmented into omic technologies, imaging technologies, immunoassays, and cytogenetics.
  • On the basis of the biomolecule, the market has been classified into genetic, protein, and glyco-biomarkers.
  • The market has been divided based on the cancer type into breast, lung, colorectal, prostate, stomach, and other cancers.
  • Based on the application, the market has been segregated into diagnostics, prognostics, risk assessment, drug discovery and development, and others.
  • On the basis of the end user, the market has been categorized into hospitals, academic and research institutions, ambulatory surgical centers, diagnostic laboratories, and others.
  • Region-wise, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been analyzed, with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Illumina Inc., Qiagen N.V., Sino Biological Inc., and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Profiling Technology, Biomolecule, Cancer Type, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Illumina Inc., Qiagen N.V., Sino Biological Inc. and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

USA: +1-631-791-1145
Follow us on twitter : @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Cancer Biomarkers Market to Reach US$ 77.0 Billion by 2032, Impelled by Rising Incidences of Cancer
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More